Suppr超能文献

腺瘤性结直肠癌患者与对照受试者的人类肠道微生物群比较:末端限制性片段长度多态性和下一代测序分析。

Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.

作者信息

Kasai Chika, Sugimoto Kazushi, Moritani Isao, Tanaka Junichiro, Oya Yumi, Inoue Hidekazu, Tameda Masahiko, Shiraki Katsuya, Ito Masaaki, Takei Yoshiyuki, Takase Kojiro

机构信息

Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Mie 510-8561, Japan.

Department of Molecular and Laboratory Medicine, Mie University School of Medicine, Tsu, Mie 514-8507, Japan.

出版信息

Oncol Rep. 2016 Jan;35(1):325-33. doi: 10.3892/or.2015.4398. Epub 2015 Nov 4.

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in Japan. The etiology of CRC has been linked to numerous factors including genetic mutation, diet, life style, inflammation, and recently, the gut microbiota. However, CRC-associated gut microbiota is still largely unexamined. This study used terminal restriction fragment length polymorphism (T-RFLP) and next-generation sequencing (NGS) to analyze and compare gut microbiota of Japanese control subjects and Japanese patients with carcinoma in adenoma. Stool samples were collected from 49 control subjects, 50 patients with colon adenoma, and 9 patients with colorectal cancer (3/9 with invasive cancer and 6/9 with carcinoma in adenoma) immediately before colonoscopy; DNA was extracted from each stool sample. Based on T-RFLP analysis, 12 subjects (six control and six carcinoma in adenoma subjects) were selected; their samples were used for NGS and species-level analysis. T-RFLP analysis showed no significant differences in bacterial population between control, adenoma and cancer groups. However, NGS revealed that i), control and carcinoma in adenoma subjects had different gut microbiota compositions, ii), one bacterial genus (Slackia) was significantly associated with the control group and four bacterial genera (Actinomyces, Atopobium, Fusobacterium, and Haemophilus) were significantly associated with the carcinoma-in-adenoma group, and iii), several bacterial species were significantly associated with each type (control: Eubacterium coprostanoligens; carcinoma in adenoma: Actinomyces odontolyticus, Bacteroides fragiles, Clostridium nexile, Fusobacterium varium, Haemophilus parainfluenzae, Prevotella stercorea, Streptococcus gordonii, and Veillonella dispar). Gut microbial properties differ between control subjects and carcinoma-in-adenoma patients in this Japanese population, suggesting that gut microbiota is related to CRC prevention and development.

摘要

在日本,结直肠癌(CRC)是癌症相关死亡的第三大主要原因。CRC的病因与众多因素有关,包括基因突变、饮食、生活方式、炎症,以及最近发现的肠道微生物群。然而,与CRC相关的肠道微生物群仍在很大程度上未被研究。本研究使用末端限制性片段长度多态性(T-RFLP)和下一代测序(NGS)来分析和比较日本对照受试者和日本腺瘤性癌患者的肠道微生物群。在结肠镜检查前,立即从49名对照受试者、50名结肠腺瘤患者和9名结直肠癌患者(9例中有3例为浸润性癌,6例为腺瘤性癌)收集粪便样本;从每个粪便样本中提取DNA。基于T-RFLP分析,选择了12名受试者(6名对照受试者和6名腺瘤性癌受试者);他们的样本用于NGS和物种水平分析。T-RFLP分析显示,对照组、腺瘤组和癌症组之间的细菌种群没有显著差异。然而,NGS显示,i)对照受试者和腺瘤性癌受试者的肠道微生物群组成不同,ii)一个细菌属(Slackia)与对照组显著相关,四个细菌属(放线菌属、阿托波氏菌属、梭杆菌属和嗜血杆菌属)与腺瘤性癌组显著相关,iii)几种细菌物种与每种类型显著相关(对照:粪甾醇真杆菌;腺瘤性癌:溶齿放线菌、脆弱拟杆菌、紧密梭菌、多变梭杆菌、副流感嗜血杆菌、粪便普雷沃菌、戈登链球菌和殊异韦荣球菌)。在这一日本人群中,对照受试者和腺瘤性癌患者的肠道微生物特性不同,这表明肠道微生物群与CRC的预防和发展有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验